SAKAR

Sakar Healthcare Share PriceSakar Healthcare

₹388.6
-2.85 (-0.73%)
As on 02 December, 2023 | 17:31 BSE: NSE: SAKARISIN: INE732S01012

Sakar Healthcare Performance

Day Range

  • Low 387.10
  • High 394.05
₹ 388.6

52 Week Range

  • Low 185.55
  • High 419.50
₹ 388.6
  • Open Price394.05
  • Previous Close391.45
  • Volume13625

Start SIP in Sakar Healthcare

Start SIP

Sakar Healthcare Share Price

  • Over 1 Month 15.43%
  • Over 3 Month 10.26%
  • Over 6 Month 44.41%
  • Over 1 Year 50.53%

Sakar Healthcare Key Statistics

P/E Ratio 57.6
PEG Ratio 15.2
Market Cap Cr 830
Price to Book Ratio 4.8
EPS 6.7
Dividend 0
Relative Strength Index 56.14
Money Flow Index 59.68
MACD Signal 11.85
Average True Range 16.81

Sakar Healthcare Investment Rating

  • Master Rating:
  • Sakar Healthcare has an operating revenue of Rs. 147.18 Cr. on a trailing 12-month basis. An annual revenue growth of 6% is not great, Pre-tax margin of 13% is healthy, ROE of 7% is fair but needs improvement. The company has a debt to equity of 57%, which is bit higher. The stock from a technical standpoint is comfortably placed above its key moving averages, around 8% and 36% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around -2% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 80 which is a GOOD score indicating consistency in earnings, a RS Rating of 69 which is FAIR indicating the recent price performance, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 122 indicates it belongs to a poor industry group of Medical-Ethical Drugs and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Sakar Healthcare Financials
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 34394133312937
Operating Expenses Qtr Cr 25303325222127
Operating Profit Qtr Cr 9989989
Depreciation Qtr Cr 4544443
Interest Qtr Cr 2222111
Tax Qtr Cr 110121-3
Net Profit Qtr Cr 4344239
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 138130
Operating Expenses Annual Cr 10099
Operating Profit Annual in Cr 3329
Depreciation Cr 1510
Interest Annual Cr 63
Tax Annual Cr 44
Net Profit Annual Cr 1315
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 3336
Cash from Investing Activity Annual Cr -74-90
Cash from Financing Annual Activity Cr 4155
Net Cash Flow Annual Cr 00
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 173128
Fixed Assets Annual Cr 273206
Total Non Current Assets Annual Cr 280218
Total Current Assets Annual Cr 5650
Total Assets Annual Cr 336268
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 9175
ROE Annual % 712
ROCE Annual % 810
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 2825
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 34394133312937
Operating Expenses Qtr Cr 25303325222127
Operating Profit Qtr Cr 9989989
Depreciation Qtr Cr 4544443
Interest Qtr Cr 2222111
Tax Qtr Cr 110121-3
Net Profit Qtr Cr 4344239
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 138130
Operating Expenses Annual Cr 10099
Operating Profit Annual in Cr 3329
Depreciation Cr 1510
Interest Annual Cr 63
Tax Annual Cr 44
Net Profit Annual Cr 1315
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 3336
Cash from Investing Activity Annual Cr -74-90
Cash from Financing Annual Activity Cr 4155
Net Cash Flow Annual Cr 00
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 173127
Fixed Assets Annual Cr 273206
Total Non Current Assets Annual Cr 280218
Total Current Assets Annual Cr 5650
Total Assets Annual Cr 336268
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 9174
ROE Annual % 712
ROCE Annual % 810
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 2825

Sakar Healthcare Technicals

EMA & SMA

Current Price
₹388.6
-2.85 (-0.73%)
pointer
  • Bullish Moving Average
  • ___
  • 11
  • Bearish Moving Average
  • ___
  • 5
  • 20 Day
  • ₹383.76
  • 50 Day
  • ₹363.85
  • 100 Day
  • ₹337.46
  • 200 Day
  • ₹301.33
  • 20 Day
  • ₹385.77
  • 50 Day
  • ₹358.93
  • 100 Day
  • ₹333.35
  • 200 Day
  • ₹284.36

Sakar Healthcare Resistance and Support

PIVOT
₹389.92
Resistance
First Resistance 392.73
Second Resistance 396.87
Third Resistance 399.68
RSI 56.14
MFI 59.68
MACD Single Line 11.85
MACD 10.62
Support
First Resistance 385.78
Second Resistance 382.97
Third Resistance 378.83

Sakar Healthcare Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 13,625 919,960 67.52
Week 27,642 1,697,772 61.42
1 Month 45,272 2,406,194 53.15
6 Month 48,104 2,311,879 48.06

Sakar Healthcare Result Highlights

Sakar Healthcare Synopsis

NSE-Medical-Ethical Drugs

Sakar Healthcare is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 133.36 Cr. and Equity Capital is Rs. 19.04 Cr. for the Year ended 31/03/2023. Sakar Healthcare Ltd. is a Public Limited Listed company incorporated on 26/03/2004 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24231GJ2004PLC043861 and registration number is 043861.
Market Cap 830
Sales 147
Shares in Float 0.98
No of funds 4
Yield
Book Value 4.27
U/D Vol ratio 1.7
LTDebt / Equity 57
Alpha 0.12
Beta 1.6

Sakar Healthcare

Owner NameSep-23Jun-23Mar-23Feb-23
Promoters 54.15%60.72%60.72%60.72%
Mutual Funds
Insurance Companies
Foreign Portfolio Investors 14.03%15.74%15.74%
Financial Institutions/ Banks
Individual Investors 16.37%18.13%18.41%18.39%
Others 15.45%21.15%5.13%5.15%

Sakar Healthcare Management

Name Designation
Mr. Sanjay S Shah Chairman & Managing Director
Mr. Aarsh S Shah Joint Managing Director
Ms. Rita S Shah Whole Time Director
Mr. Shailesh B Patel Ind. Non-Executive Director
Mr. Prashant C Srivastav Ind. Non-Executive Director
Mr. Hemendra C Shah Ind. Non-Executive Director

Sakar Healthcare Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Sakar Healthcare Corporate Action

Date Purpose Remarks
2023-11-06 Quarterly Results
2023-05-26 Audited results
2023-02-10 Quarterly Results
2023-01-21 Others To consider raising of funds
2022-10-22 Quarterly Results

Sakar Healthcare FAQs

What is Share Price of Sakar Healthcare ?

Sakar Healthcare share price is ₹388 As on 02 December, 2023 | 17:17

What is the Market Cap of Sakar Healthcare ?

The Market Cap of Sakar Healthcare is ₹829.7 Cr As on 02 December, 2023 | 17:17

What is the P/E ratio of Sakar Healthcare ?

The P/E ratio of Sakar Healthcare is 57.6 As on 02 December, 2023 | 17:17

What is the PB ratio of Sakar Healthcare ?

The PB ratio of Sakar Healthcare is 4.8 As on 02 December, 2023 | 17:17

Q2FY23